Skip to main content
Loading...

CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing performance

Manchester, UK (20 June 2023) – CARBOGEN AMCIS Manchester, a member of the Switzerland-based CARBOGEN AMCIS Group, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, won the Manufacturing and Resource Efficiency Award at the prestigious Chemistry Industry Awards last week.

CARBOGEN AMCIS Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products. The two-year award-winning program resulted in a 75% productivity increase and a step change in its approach to sustainability. Productivity benefits were reinvested back into the business to support the health and wellbeing of the over ninety-employee strong team, leading to a 20% increase in employee retention.

The Chemical Industry Awards, held at Kimpton Clocktower Hotel in Manchester, are the premier accolades for the UK chemical industry to highlight and promote excellent performance. Hosted by comedian Justin Moorhouse, CARBOGEN AMCIS took home the award for demonstrating significant recycling and production process improvements.

Carl Baker, Site Director of CARBOGEN AMCIS Manchester, said: “We are proud to win recognition for our best in class manufacturing performance, demonstrating significant improvements to resource efficiency within the last two years.

“The award further highlights the full commitment of our team to deliver world class services and I would like to congratulate everyone at CARBOGEN AMCIS Manchester for their contributions.”

CARBOGEN AMCIS Manchester is home to appropriate-GMP technologies that support the pharmaceutical, cosmetic and fine chemical industries. The facility focuses on the development of robust, efficient and safe processes for the manufacture of commercial quantities of high quality goods.



CARBOGEN AMCIS AG (www.carbogen-amcis.com) is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development, allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is a wholly owned subsidiary of Dishman Carbogen Amcis Limited., Ahmedabad, India 


Dishman Carbogen Amcis Limited (www.imdcal.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. Dishman Carbogen Amcis group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe and in India.